Dihydroartemisinin exerts its anticancer activity through depleting cellular iron via transferrin receptor-1.
about
Artemisinin and Its Derivatives as a Repurposing Anticancer Agent: What Else Do We Need to Do?Dihydroartemisinin promotes angiogenesis during the early embryonic development of zebrafishFerristatin II promotes degradation of transferrin receptor-1 in vitro and in vivo.Effects of benzo[a]pyrene exposure on human hepatocellular carcinoma cell angiogenesis, metastasis, and NF-κB signaling.Dihydroartemisinin induces apoptosis preferentially via a Bim-mediated intrinsic pathway in hepatocarcinoma cells.Mechanisms of Dihydroartemisinin and Dihydroartemisinin/Holotransferrin Cytotoxicity in T-Cell Lymphoma Cells.Magnolol inhibits growth of gallbladder cancer cells through the p53 pathway.Dihydroartemisinin prevents breast cancer-induced osteolysis via inhibiting both breast caner cells and osteoclasts.Repurposing the anti-malarial drug artesunate as a novel therapeutic agent for metastatic renal cell carcinoma due to its attenuation of tumor growth, metastasis, and angiogenesis.Organism-like formation of Schistosoma hemozoin and its function suggest a mechanism for anti-malarial action of artemisinin.Phytoagents for cancer management: regulation of nucleic acid oxidation, ROS, and related mechanisms.A review of dihydroartemisinin as another gift from traditional Chinese medicine not only for malaria control but also for schistosomiasis control.Updates on artemisinin: an insight to mode of actions and strategies for enhanced global production.Artemisinin rewires the protein interaction network in cancer cells: network analysis, pathway identification, and target prediction.Cyclic AMP efflux inhibitors as potential therapeutic agents for leukemia.Metabolic analyses elucidate non-trivial gene targets for amplifying dihydroartemisinic acid production in yeast.Impaired Transferrin Receptor Palmitoylation and Recycling in Neurodegeneration with Brain Iron Accumulation.Antitumor Research on Artemisinin and Its Bioactive Derivatives.
P2860
Q28066236-DA3D7DE5-B6F8-4C52-BA00-9A342DDAF9C3Q34740860-C89D5D5D-3A42-4D5F-9AEB-EEE2DE276988Q34875712-6DFAFC8D-E2B9-4C9E-8091-4E794B5A4290Q35144658-8224A377-AABC-4360-84B5-508907E3A7FDQ35620926-1C98C432-7C4C-4716-8019-F6D938B56ACAQ35821436-167B2BBE-035D-4F70-807D-DFB19ADBB524Q36262922-D1AAF2D4-7C1A-4579-B4F6-4B2EA607C7F6Q36442668-D28422FA-2F1D-457D-9B1C-530AAD6894EAQ36545062-F5E2F05E-68C4-4BC2-A763-CF698FE7F502Q37303426-5B4B92BE-23AD-4239-A4F2-8653A357B185Q37455520-180226BF-77D0-406A-8954-7F692AC5FC8BQ38194450-2C0D5979-70C2-461A-98E2-7FAB2F497A14Q38392573-6F92D1CB-42C3-4C32-B580-F0564F1C50A9Q39089032-48C8A27B-F5E2-4DBD-A10C-5446C09CF0CEQ39809596-8DBEA51A-978C-483E-9715-332BEB52D68EQ43073354-A53F2EC7-F078-4275-8E79-B0C6E2B0F1C7Q50209845-A98C9271-B6DE-4BA9-B295-4D1294D8B5DCQ52597265-B9F3E93B-E535-461C-B8CF-7D6AB42627FB
P2860
Dihydroartemisinin exerts its anticancer activity through depleting cellular iron via transferrin receptor-1.
description
2012 nî lūn-bûn
@nan
2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Dihydroartemisinin exerts its ...... on via transferrin receptor-1.
@ast
Dihydroartemisinin exerts its ...... on via transferrin receptor-1.
@en
Dihydroartemisinin exerts its ...... on via transferrin receptor-1.
@nl
type
label
Dihydroartemisinin exerts its ...... on via transferrin receptor-1.
@ast
Dihydroartemisinin exerts its ...... on via transferrin receptor-1.
@en
Dihydroartemisinin exerts its ...... on via transferrin receptor-1.
@nl
prefLabel
Dihydroartemisinin exerts its ...... on via transferrin receptor-1.
@ast
Dihydroartemisinin exerts its ...... on via transferrin receptor-1.
@en
Dihydroartemisinin exerts its ...... on via transferrin receptor-1.
@nl
P2093
P2860
P1433
P1476
Dihydroartemisinin exerts its ...... on via transferrin receptor-1.
@en
P2093
Junyang Li
Naiyuan Zhou
Xinying Yang
P2860
P304
P356
10.1371/JOURNAL.PONE.0042703
P407
P577
2012-08-10T00:00:00Z